Molecular Partners AG
Clinical-stage company developing novel protein therapeutics for oncology.
MOLN | SW
Overview
Corporate Details
- ISIN(s):
- CH0256379097 (+1 more)
- LEI:
- 875500AXMLDAZ4D21744
- Country:
- Switzerland
- Address:
- Wagistrasse 14, 8952 Schlieren
- Sector:
- Manufacturing
Description
Molecular Partners AG is a clinical-stage biopharmaceutical company pioneering the design and development of a novel class of protein therapeutics known as DARPin® therapies. DARPins (Designed Ankyrin Repeat Proteins) are a proprietary class of small, custom-built proteins engineered to bind to specific disease targets with high potency and specificity. The company leverages its platform to create multi-specific drug candidates capable of engaging multiple targets or pathways simultaneously. The development pipeline is primarily focused on advancing innovative treatments in oncology, with clinical programs targeting serious diseases such as acute myeloid leukemia (AML). The company's approach aims to address complex medical challenges by utilizing the unique properties of its engineered protein platform.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-07-07 07:25 |
Molecular Partners AG: Molecular Partners Successfully Completes the Launch of …
|
English | 17.3 KB | ||
| 2020-04-19 23:15 |
Molecular Partners Initiates Anti-COVID-19 Therapeutic Program Leveraging Multi…
|
English | 12.0 KB |
Automate Your Workflow. Get a real-time feed of all Molecular Partners AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Molecular Partners AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Molecular Partners AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-09-09 | N/A | Executive member | Sell | None | 47,784.80 CHF |
| 2024-09-09 | N/A | Executive member | Sell | None | 13,822.40 CHF |
| 2024-04-02 | N/A | Executive member | Sell | None | 243,000.00 CHF |
| 2023-11-01 | N/A | Executive member | Buy | None | 31,760.55 CHF |
| 2022-02-15 | N/A | Executive member | Sell | None | 2,410,500.00 CHF |
| 2022-02-15 | N/A | Executive member | Sell | None | 1,607,000.00 CHF |
Peer Companies
